Meetings and Reports. (a) [***] during each Contract Year from the Product Schedule Date until the first approval of a BLA (or equivalent Regulatory Approval) for Product, within [***] days of Moderna’s written request, the Parties will meet in person [***] for AstraZeneca to provide Moderna with an update on the Development and Commercialization of Product and the related Subject Constructs. During such meeting, AstraZeneca will disclose to Moderna a summary of all material information regarding such Development and Commercialization.
Appears in 4 contracts
Samples: Option Agreement, Option Agreement (Moderna, Inc.), Option Agreement (Moderna, Inc.)